Skip to content

Powerlink Bifurcated Stent Graft Long-Term Follow-up Study

Endologix Powerlink Long-Term Follow-up Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00543270
Enrollment
258
Registered
2007-10-12
Start date
2005-10-31
Completion date
2009-11-30
Last updated
2021-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Aortic Aneurysm

Keywords

EVAR, AAA, Aneurysm, Powerlink

Brief summary

Endologix Infrarenal Bifurcated Stent Graft Study

Interventions

DEVICEPowerlink infrarenal bifurcated stent graft delivery system

Endovascular abdominal aortic aneurysm repair

PROCEDUREOpen Surgery

Open surgical abdominal aortic aneurysm repair

Sponsors

Endologix
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All surviving patients from the original study cohort who received the Powerlink device * All surviving patients from the original study cohort who were assigned to the open surgical control arm

Design outcomes

Primary

MeasureTime frameDescription
No of Subjects with Major adverse eventsAt 1 YearAneurysm-related mortality, aneurysm rupture, conversion to open repair, coronary intervention, myocardial infarction, renal failure, respiratory failure, secondary procedure, and stroke
All Cause MortalityAt 1 YearNo of deaths reported through 1 year

Secondary

MeasureTime frameDescription
Stent Graft Performance30 DaysTotal number of Subjects with Stent fracture, Stent Graft Migration, Stent Graft patency and Device Migration
Clinical Utility OutcomesDuring the ProcedureEstimated anesthesia time, fluoroscopy time, procedure time
Aneurysm Morphology6 MonthsChange in aneurysm sac diameter from first post-procedural CT scan (30 days) to 6 Months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026